COST-EFFECTIVENESS ANALYSIS OF DIAGNOSTICS OF TUBERCULOSIS INFECTION IN THE RUSSIAN FEDERATION WITH THE USE OF TUBERCULOUS RECOMBINANT ALLERGEN

被引：0
|
作者：
Holownia, M. [1 ]
Solodun, I [1 ]
Bashlakova, E. [1 ]
Ermolaeva, T. [1 ]
Davydovskaya, M. [1 ]
Evdoshenko, E. [1 ]
机构：
[1] Moscow Dept Healthcare, State Budgetary Inst Moscow City, Ctr Clin Trials Management & Performance, Moscow, Russia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1997
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD56
引用
收藏
页码：A694 / A694
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis
    Luciene C Scherer
    Rosa D Sperhacke
    Antonio Ruffino-Netto
    Maria LR Rossetti
    Claudia Vater
    Paul Klatser
    Afrânio L Kritski
    BMC Infectious Diseases, 9
  • [42] Tuberculosis in Ethiopia: Optimal Intervention Strategies and Cost-Effectiveness Analysis
    Mengistu, Ashenafi Kelemu
    Witbooi, Peter J.
    AXIOMS, 2022, 11 (07)
  • [43] Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis
    Scherer, Luciene C.
    Sperhacke, Rosa D.
    Ruffino-Netto, Antonio
    Rossetti, Maria L. R.
    Vater, Claudia
    Klatser, Paul
    Kritski, Afranio L.
    BMC INFECTIOUS DISEASES, 2009, 9
  • [44] Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis
    Fredrik Salvesen Haukaas
    Trude Margrete Arnesen
    Brita Askeland Winje
    Eline Aas
    The European Journal of Health Economics, 2017, 18 : 405 - 415
  • [45] A decade of investment in infection prevention: A cost-effectiveness analysis
    Dick, Andrew W.
    Perencevich, Eli N.
    Pogorzelska-Maziarz, Monika
    Zwanziger, Jack
    Larson, Elaine L.
    Stone, Patricia W.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2015, 43 (01) : 4 - 9
  • [46] COST - EFFECTIVENESS ANALYSIS OF VILANTEROL/FLUTICASONE FUROATE FOR ASTHMA TREATMENT IN THE RUSSIAN FEDERATION
    Makarova, E.
    Yagudina, R.
    Kulikov, A.
    VALUE IN HEALTH, 2018, 21 : S412 - S412
  • [47] COST-EFFECTIVENESS ANALYSIS OF THE PRIMOVACCINATION OF NEWBORNS AGAINST TUBERCULOSIS IN SLOVAKIA
    Marusakova, E.
    Bielik, J.
    Frecerova, K.
    Nevicka, E.
    Sedlakova, D.
    VALUE IN HEALTH, 2012, 15 (07) : A393 - A393
  • [48] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    G. B. Gomez
    D. W. Dowdy
    M. L. Bastos
    A. Zwerling
    S. Sweeney
    N. Foster
    A. Trajman
    M. A. Islam
    S. Kapiga
    E. Sinanovic
    G. M. Knight
    R. G. White
    W. A. Wells
    F. G. Cobelens
    A. Vassall
    BMC Infectious Diseases, 16
  • [49] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    Gomez, G. B.
    Dowdy, D. W.
    Bastos, M. L.
    Zwerling, A.
    Sweeney, S.
    Foster, N.
    Trajman, A.
    Islam, M. A.
    Kapiga, S.
    Sinanovic, E.
    Knight, G. M.
    White, R. G.
    Wells, W. A.
    Cobelens, F. G.
    Vassall, A.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [50] Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
    Watt, Maureen
    Dinh, Aur Elien
    Le Monnier, Alban
    Tilleul, Patrick
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 678 - 686
12345